Key Insights

Highlights

Success Rate

86% trial completion

Published Results

27 trials with published results (15%)

Research Maturity

84 completed trials (46% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.6%

14 terminated out of 184 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

13%

24 trials in Phase 3/4

Results Transparency

32%

27 of 84 completed with results

Key Signals

27 with results86% success14 terminated

Data Visualizations

Phase Distribution

134Total
Not Applicable (74)
Early P 1 (1)
P 1 (14)
P 2 (21)
P 3 (18)
P 4 (6)

Trial Status

Completed84
Recruiting44
Unknown21
Terminated14
Not Yet Recruiting9
Active Not Recruiting6

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 84 completed trials

Clinical Trials (184)

Showing 20 of 20 trials
NCT02443857Not ApplicableCompletedPrimary

Feasibility of a New Pediatric Arm Rehabilitation Robot ChARMin

NCT04746820Not ApplicableRecruitingPrimary

Functional Near-infrared Spectroscopy in Unconscious Patients

NCT04289909Not ApplicableCompleted

Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)

NCT07250737Unknown

Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping

NCT06088121Not ApplicableRecruiting

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

NCT06249776Not ApplicableCompleted

Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial

NCT06672237Phase 3Recruiting

A Phase 3 Study of NTLA-2001 in ATTRv-PN

NCT07185022Not ApplicableRecruiting

Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion

NCT03911388Phase 1Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NCT05318976Phase 2Completed

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

NCT05508789Phase 3Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

NCT04698421RecruitingPrimary

Collection of Biological Samples From Patients With Rare Neurological Diseases

NCT03678194Not ApplicableRecruiting

Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application

NCT03179631Phase 3Completed

Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy

NCT05522387Phase 2Terminated

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

NCT03540485Phase 1Terminated

Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis

NCT07324330Not ApplicableRecruiting

Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity

NCT07340775Not ApplicableNot Yet Recruiting

Hypersensitivity to Amylin in Post-Traumatic Headache

NCT06237218Not ApplicableRecruitingPrimary

Effects of the COTID (Community Occupational Therapist in Dementia) Program and Usual Occupational Therapy Care on Recurrence of Falls at 12 Months in Elderly People With Neurocognitive Disorders Who Had Been Hospitalized for Falls, After Their Return Home

NCT07340788Not ApplicableNot Yet Recruiting

Amylin-Induced Migraine Attacks Without Aura

Scroll to load more

Research Network

Activity Timeline